2021a, b
Applying for Novo Nordisk's Patient Assistance Program (PAP) Novo Nordisk offers patient assistance programs to help individuals afford their medications, especially those who are uninsured or underinsured
For activity screening, we adapted a GSTO1 substrate assay that relies on the quantification of the reduction of S -(4-nitrophenacyl)glutathione (4-NPG), a GSTO1-specific substrate 17 , using recombinant human GSTO1 in a high-throughput screening format
Yoon H, Park S, Jun YK, Choi Y, Shin CM, Park YS, et al
10.1038/embor.2012.156 54 KumarS.KaurA.ChattopadhyayB.BachhawatA
This led to clinical trials specifically for obesity, and several are now FDA-approved for weight management